These observations favor the possibility that IDH mutations in MPN are early genetic triggers of leukemic transformation supporting the model by Yan et al, which suggested IDH mutations occur early during gliomagenesis and provide progression from low-grade or anaplastic astrocytomas to secondary glioblastomas [7]. The gene discussed is IDH1; the disease is myeloproliferative disorder.